^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    sotrastaurin (AEB071)

    i
    Company:
    Novartis
    Drug class:
    PKC inhibitor
    Related drugs:
    Apply
    Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation (NCT02285244)
    Phase 2
    James Blachly
    Withdrawn
    Last update posted :
    04/05/2017
    Initiation :
    03/12/2015
    Primary completion :
    03/12/2015
    Completion :
    03/12/2015
    CCND1 • PLCG2
    |
    CCND1 overexpression
    |
    sotrastaurin (AEB071)